Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson's Disease
The study aims to investigate whether activating TRPML1 by a novel, small molecule modulator, will enhance the lysosomal membrane calcium ion channel to restore lysosomal function and help with clearance of alpha-synuclein, the protein that is linked to the disease.
"We are honored to receive this generous grant from The Michael J. Fox Foundation," said Valerie Cullen, PhD, Principal Investigator and SVP of Research and Translation at Lysoway. "TRPML1 is a high value target due to its pivotal role in sensing and responding to cellular stress. By activating this ion channel, we can engage multiple beneficial pathways that restore autophagy/lysosomal homeostasis and bolster cellular resilience. Our lead development candidate is both orally bioavailable and highly brain-penetrant, offering strong potential to modify disease progression in Parkinson's Disease."
Yongchang Qiu, PhD, Founder and Chief Executive Officer of Lysoway Therapeutics, added "This funding underscores growing confidence in TRPML1 as a compelling target for Parkinson's disease. It will allow us to accelerate development of our lead TRPML1 agonist and to establish key biomarkers for target engagement, with the goal of initiating first-in-human clinical trials early next year."
About Lysoway Therapeutics, Inc.Based in Cambridge, MA, Lysoway Therapeutics is a leader in developing therapeutically viable lysosomal ion channel modulators. The company is advancing a pipeline of small molecule activators targeting these channels to treat neurodegenerative diseases. Learn more at www.lysoway.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250805132586/en/
Contacts
Media contact: Info@lysoway.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
a minute ago
- New York Times
Charleston's Climate Lawsuit Against Oil Giants Is Dismissed
A judge in Charleston, S.C., dismissed on Wednesday the city's lawsuit against oil and gas companies over their role in climate change, ruling that the case raised questions that were far beyond the bounds of state laws. During two days of hearings in May, lawyers for the city argued that the companies, ranging from giants like Exxon Mobil and Chevron to local firms, had covered up what they knew about the dangers of greenhouse gas emissions. They accused the companies of mounting a disinformation campaign to cast doubt on climate science and failing to warn the public about the dangers ahead. Those actions increased demand for fossil fuels, which led to emissions and the grave risks linked to climate change that the historic coastal city now faces, including flooding and sea-level rise, they argued. The case cited state tort laws and the state's Unfair Trade Practices Act and sought funds for adaptation and mitigation projects. In his 45-page decision, Judge Roger M. Young wrote that while the lawyers argued the claims were about deception, 'they are premised on, and seek redress for, the effects of greenhouse gas emissions.' He said that those issues fall squarely under federal and not state law, and that the court lacked jurisdiction over out-of-state companies. He cited a 2021 decision by the U.S. Court of Appeals for the Second Circuit in a similar lawsuit filed by New York City against oil companies. In that case, Judge Richard J. Sullivan of the Circuit Court addressed whether the municipalities could use state tort laws to hold multinational companies liable for damages caused by greenhouse gas emissions. 'Given the nature of the harm and the existence of a complex web of federal and international environmental law regulating such emissions, we hold that the answer is 'no,'' Judge Sullivan wrote. Want all of The Times? Subscribe.
CBS News
a minute ago
- CBS News
Long Island's historic Oheka Castle files for bankruptcy
Long Island's historic Oheka Castle estate has filed for bankruptcy. With its lush gardens, fountain and European ambiance, the 443-acre French-style chateau has been the backdrop for magical moments including weddings, movie shoots, music videos and more. It's listed on the National Register of Historic Places and Historic Hotels of America. "The name itself comes from Otto Herman Kahn. He was the original builder of the castle. It was one of his six summer homes," hotel manager Steven Kessler said. It has a rich history, which is all part of its charm. "We became a retreat for sanitation workers from the New York City Department of Sanitation. We also were a school for radio operators in World War II. The last thing we were was Eastern Military Academy," Kessler said. But the historic treasure, which is also the second largest private estate in the country, is facing financial trouble. Its owner Gary Melius filed for Chapter 11 bankruptcy. According to court documents, the property owes more than $60 million to creditors. "Right now, it's really just restructuring of pre-existing debt," Kessler said. Oheka Castle hosts over 200 events every year - most of them weddings. Kessler said that will not change. "You can come here for dinner, anniversary, luxury weddings," Kessler said. "We are open for business. We have all of our events for 2025-2026. Everything is still happening." Ashley Pastore got married at Oheka Castle in 2023. "It's every girl's dream to get married at Oheka Castle," she said. "Any excuse we have to go back, we go." New Yorkers say it's a staple on Long Island, and they want to see it preserved for generations to come - everything from its grand staircase to its formal gardens. "You could walk into that venue and not need anything. It's extraordinary. You could get married there and not put one decoration up. It's history itself," Pastore said. "We're always trying to preserve a piece of Gold Coast history, so that others can come and visit us, and experience what it was like to be in the Gatsby era," Kessler said. Mansion tours are also still available.
Washington Post
a minute ago
- Washington Post
Allient: Q2 Earnings Snapshot
AMHERST, N.Y. — AMHERST, N.Y. — Allient Inc. (ALNT) on Wednesday reported second-quarter net income of $5.6 million. The Amherst, New York-based company said it had profit of 34 cents per share. Earnings, adjusted for amortization costs and restructuring costs, came to 57 cents per share.
